These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 18275176)

  • 1. Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment.
    Wu X; Xu Y; Liang Q; Yang X; Huang J; Wang J; Zhang H; Shi J
    Front Pharmacol; 2022; 13():875372. PubMed ID: 35614940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Determinants of Isoform Selectivity in PI3K Inhibitors.
    Miller MS; Thompson PE; Gabelli SB
    Biomolecules; 2019 Feb; 9(3):. PubMed ID: 30813656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of the binding mode of a new class of phosphoinositide 3-kinase α-selective inhibitors using in vitro mutagenesis of non-conserved amino acids and kinetic analysis.
    Zheng Z; Amran SI; Zhu J; Schmidt-Kittler O; Kinzler KW; Vogelstein B; Shepherd PR; Thompson PE; Jennings IG
    Biochem J; 2012 Jun; 444(3):529-35. PubMed ID: 22502592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular simulation of a series of benzothiazole PI3Kα inhibitors: probing the relationship between structural features, anti-tumor potency and selectivity.
    Wang J; Wang F; Xiao Z; Sheng G; Li Y; Wang Y
    J Mol Model; 2012 Jul; 18(7):2943-58. PubMed ID: 22139479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of molecular recognition of phosphoinositide-3-kinase α inhibitor through molecular dynamics simulation.
    Li Y; Zhang J; He D; Liang Q; Wang Y
    J Mol Model; 2012 May; 18(5):1907-16. PubMed ID: 21870199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazolidinedione-based PI3Kα inhibitors: an analysis of biochemical and virtual screening methods.
    Pinson JA; Schmidt-Kittler O; Zhu J; Jennings IG; Kinzler KW; Vogelstein B; Chalmers DK; Thompson PE
    ChemMedChem; 2011 Mar; 6(3):514-22. PubMed ID: 21360822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docking studies on isoform-specific inhibition of phosphoinositide-3-kinases.
    Sabbah DA; Vennerstrom JL; Zhong H
    J Chem Inf Model; 2010 Oct; 50(10):1887-98. PubMed ID: 20866085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore modeling and 3D-QSAR analysis of phosphoinositide 3-kinase p110alpha inhibitors.
    Li Y; Wang Y; Zhang F
    J Mol Model; 2010 Sep; 16(9):1449-60. PubMed ID: 20169382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus model for identification of novel PI3K inhibitors in large chemical library.
    Liew CY; Ma XH; Yap CW
    J Comput Aided Mol Des; 2010 Feb; 24(2):131-41. PubMed ID: 20148286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based 3D-QSAR studies on heteroarylpiperazine derivatives as 5-HT3 receptor antagonists.
    Zhou YJ; Zhu LP; Tang Y; Ye DY
    Eur J Med Chem; 2007 Jul; 42(7):977-84. PubMed ID: 17331624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
    Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoinositide-3-kinases (PI3Ks): combined comparative modeling and 3D-QSAR to rationalize the inhibition of p110alpha.
    Frédérick R; Denny WA
    J Chem Inf Model; 2008 Mar; 48(3):629-38. PubMed ID: 18275176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus superiority of the pharmacophore-based alignment, over maximum common substructure (MCS): 3D-QSAR studies on carbamates as acetylcholinesterase inhibitors.
    Chaudhaery SS; Roy KK; Saxena AK
    J Chem Inf Model; 2009 Jun; 49(6):1590-601. PubMed ID: 19441865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.